J and J Snack Foods News

More than 800 pharmaceutical jobs will be leaving New Jersey starting in August.

Cynthia Guilez, 46, of 1344 McKinley, was arrested on a Municipal Court warrant for failure to appear.

Look to history for a sense of the importance of today's medical advances. Most authorities recognize TR Ashworth, writing in the Australian Medical Journal, as making the first discovery of cells in the blood ...

Think of IdeaPoint as an online matchmaker bringing biotech inventors and biopharma companies together.

COURTS Convicted Weiss wants back pay Convicted class-action lawyer Melvyn Weiss asked a court to authorize his old firm, now called Milberg, to pay him for his work there.

Decentralizing management is a good way to spark innovation and train corporate leaders, according to William Weldon , CEO of Johnson & Johnson , maker of Band-Aids and Tylenol.

Fitch Ratings on Wednesday affirmed Johnson & Johnson's debt ratings and said ratings outlook was stable for $11.4 billion of debt.

Diversified health care products company Johnson & Johnson said Tuesday it is considering an undisclosed buyout offer for its professional wound care business from One Equity Partners.

The companys growth plan is based on three strategic measures: expansion in developing markets, new technologies, and selected acquisitions.

NEW YORK -- Johnson & Johnson's blockbuster anti-psychotic drug Risperdal will face generic competition, as Teva Pharmaceutical Industries Ltd.

In these times of huge market drops and stock volatility, where would you invest safely if you wanted to? Here's a bit of wisdom from a couple of local brokers: v Buy shares of companies whose products ...

A handwriting expert called by the defense testified yesterday that Susan Romanyszyn "is not the author" of any of the 15 written threats found last October on notes and walls throughout the Warminster ...

At The Motley Fool, we poke plenty of fun at Wall Street analysts and their endless cycle of upgrades, downgrades, and "initiating coverage at neutral." So you might think we'd be the last people to give ...

On June 19, 2008, Standard & Poor's Ratings Services assigned its 'AAA' rating to New Brunswick, N.J.-based Johnson & Johnson's notes which are being offered in two tranches: $900 million at 5.15%, maturing ...

Proposed plans for a North Brunswick Train Station and Transit Village just got a $3 million boost from the state Department of Transportation, which will help fund a feasibility study.

A Johnson & Johnson unit bought a Swedish company that develops technology for faster diagnostic tests of patient blood samples.

SILVER SPRING, Maryland - Johnson & Johnson's experimental drug ustekinumab should be approved for treating adults with moderate or severe psoriasis, a U.S. advisory panel unanimously ruled on Tuesday.Panel ...

The legal dispute was over the Red Cross' use of a red cross in commercial dealings; Johnson & Johnson believed itself to be the exclusive owner of a logo with two red lines intersecting.

By Lisa Richwine

WASHINGTON (Reuters) - An experimental psoriasis drug from Johnson & Johnson is effective at relieving symptoms but extended use may raise the risk of cancer, U.S. drug reviewers said in documents released on Friday.

"Long-term use of ustekinumab may lead to increased risk of tumor development in psoriasis patients," Food and Drug Administration reviewers wrote in an analysis prepared for an advisory panel that is set to discuss the drug next week.

A spokesman for J&J's Centocor unit said the risk of cancer was theoretical and the company planned to monitor long-term safety after approval.

An experimental treatment for rheumatoid arthritis being developed by Johnson & Johnson and Schering-Plough Corp appeared to be effective and very safe in three late-stage trials, the companies said on Tuesday.